CDTX CDTX

Cidara Therapeutics Stock Price

0.6738
0.0068 (1.02%)
Upgrade to Real-Time
Regular Market
0.6738
Volume 267,970
Bid Price 0.6681
Ask Price 0.6738
News -
Day High 0.6799

Low
0.40

52 Week Range

High
2.39

Day Low 0.6499
Company Name Stock Ticker Symbol Market Type
Cidara Therapeutics Inc CDTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0068 1.02% 0.6738 12:56:34
Open Price Low Price High Price Close Price Prev Close
0.67 0.6499 0.6799 0.667
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
757 267,970 $ 0.6664485 $ 178,588 - 0.40 - 2.39
Last Trade Time Type Quantity Stock Price Currency
13:00:08 100 $ 0.6738 USD

Period:

Draw Mode:

Cidara Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 47.22M 70.08M 68.99M $ 49.57M $ -40.14M -0.86 -0.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 196.00k 3.50%

more financials information »

Cidara Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CDTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.63010.700.58620.6491432507,0870.04376.94%
1 Month0.6910.880.570.7281531938,033-0.0172-2.49%
3 Months0.450.880.400.6613241551,9460.223849.73%
6 Months0.811.060.400.6778863398,451-0.1362-16.81%
1 Year1.672.390.401.18522,422-0.9962-59.65%
3 Years1.344.450.402.06458,019-0.6662-49.72%
5 Years5.758.800.402.42327,337-5.08-88.28%

Cidara Therapeutics Description

Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's Rezafungin is a novel molecule in the echinocandin class of antifungals. It is developing rezafungin for the first-line treatment and prevention of serious, invasive fungal infections which are associated with high mortality rates.


Your Recent History
NASDAQ
CDTX
Cidara The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now